Takeda Pharmaceutical Co Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

17.40$ -0.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

Takeda Pharmaceutical Co Ltd (TAK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,219,900 million JPY. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of JPY.

Tick rows to compare them in a chart (up to 4)

Income Statement TAK
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	416,795	465,045	416,205	448,240	433,177	488,151	400,963	449,834	430,777	499,402	717,211	849,121	811,048	859,317	771,702	801,850	788,935	836,753	770,274	949,603	844,819	901,294	873,289	972,465	1,002,307	1,096,551	956,156	1,058,618	1,043,089	1,111,186	1,050,869	1,207,990	1,176,038	1,144,124	1,053,400	1,106,685	1,112,796	1,213,211	1,114,649	1,219,900	4,660,556
Cost of Revenue	141,462	147,490	134,407	120,868	121,873	142,287	110,892	120,590	110,751	138,514	289,835	300,592	271,710	279,575	248,181	238,078	249,642	253,142	253,446	241,264	275,797	281,404	308,380	292,882	305,445	335,973	309,772	321,114	343,582	379,481	387,328	386,954	394,311	416,874	382,100	384,675	380,061	552,866	570,839	406,676	1,910,441
Gross Profit	275,333	317,555	281,798	327,372	311,304	345,864	290,071	329,244	320,026	360,888	427,376	548,529	539,338	579,742	523,521	563,772	539,293	583,611	516,828	708,339	569,022	619,890	564,909	679,583	696,862	760,578	646,384	737,504	699,507	731,705	663,541	821,036	781,727	727,250	671,300	722,010	732,735	660,346	543,810	813,224	2,750,115
Research & Development	75,416	71,833	88,504	75,688	79,408	81,564	88,782	71,966	79,466	77,461	139,405	116,866	113,497	122,709	139,309	106,821	118,157	117,566	113,289	122,480	131,600	128,378	143,628	143,607	154,145	174,629	160,944	162,741	183,946	187,381	195,856	168,463	175,564	170,193	216,000	143,891	161,482	178,394	198,908	167,395	706,180
Selling, General & Administrative	145,984	–	–	145,867	151,396	1,412	1,622	145,028	148,755	1,404	269,922	239,213	223,256	249,210	202,374	202,374	216,257	222,644	234,388	219,843	212,011	231,078	223,429	231,480	248,734	262,299	254,796	248,113	252,952	267,520	285,234	270,030	268,282	270,588	295,866	255,885	253,551	282,783	291,996	286,513	1,114,843
Total Operating Expenses	266,190	262,200	343,361	132,397	271,929	257,925	370,569	230,374	246,940	248,424	551,431	538,663	498,894	526,231	585,657	396,487	490,990	440,470	366,288	459,787	471,595	503,405	566,527	529,067	592,425	613,588	557,820	568,933	748,850	626,791	673,610	654,707	597,480	660,308	746,200	537,444	663,740	466,282	496,269	611,807	2,238,098
Operating Income	9,143	55,354	-61,563	194,975	39,374	87,938	-80,498	98,870	73,086	112,464	-79,451	9,866	40,444	53,511	-62,136	167,285	48,303	143,141	150,540	248,552	97,427	116,484	-1,619	150,515	104,438	146,990	88,562	168,571	-49,341	104,914	-10,069	166,329	184,247	66,942	-74,900	184,566	68,995	194,063	47,542	201,417	512,017
Interest Expense	5,749	5,889	6,240	9,964	6,019	6,777	9,167	14,794	9,109	22,275	6,640	46,064	53,204	43,737	549	46,846	63,874	62,669	78,366	71,068	39,676	46,706	24,261	55,469	53,803	79,749	324	59,575	401	66,568	318	59,691	68,454	207	330	107,158	83,138	125,859	44,451	63,845	317,293
Pre-Tax Income	5,342	53,801	-65,473	198,242	34,746	54,903	-70,686	93,863	66,917	47,599	-113,483	-25,186	-2,371	24,842	-116,762	130,291	-4,730	109,796	130,878	222,978	61,447	72,193	-54,047	155,970	65,418	107,153	47,915	135,451	-95,980	61,260	-47,522	136,604	119,372	26,407	-107,300	150,630	28,174	136,281	-53,443	162,718	273,730
Income Tax Expense	-19,923	11,373	-12,950	53,253	7,065	-13,116	-16,705	15,783	18,508	9,735	-58,144	-4,550	-56,287	56,948	-118,324	47,772	-8,800	17,358	-66,266	85,252	15,452	14,373	-42,672	50,452	2,817	-11,996	16,779	45,627	-48,009	-44,496	-44,528	41,304	27,266	2,572	-4,200	26,351	39,903	30,675	-28,740	49,462	91,299
Net Income	24,773	41,374	-50,734	144,789	28,028	68,089	-54,020	78,242	48,426	37,766	-55,308	-20,660	53,844	-32,221	1,724	82,511	4,037	92,359	197,098	137,684	45,964	57,770	-11,358	105,014	61,742	119,127	31,134	89,395	-48,030	105,720	-3,018	95,248	92,046	23,789	-103,200	124,243	-11,802	105,510	-24,766	113,197	182,139
EBITDA	73,589	101,384	-8,012	254,204	77,567	105,249	-22,164	147,219	115,440	108,203	84,429	197,210	216,471	164,530	54,021	318,724	187,247	282,891	194,856	436,994	241,770	266,181	131,407	369,225	286,179	363,782	199,533	366,109	202,284	257,026	259,235	388,515	380,278	193,007	181,269	439,424	316,467	456,220	157,888	337,491	1,268,066

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings